SCHEDULE 14A

Company

REGENERON PHARMACEUTICALS, INC.

Filed

May 1, 2000

Period of Report

June 9, 2000

Accession Number

0000889812-00-002043

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →